Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells-Reference-Cited by-同舟云学术

Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells

Published:2007-12-21 Issue:3 Volume:73 Page:1005-1012
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Seo Sung-Keum,Jin Hyeon-Ok,Lee Hyung-Chahn,Woo Sang-Hyeok,Kim Eun-Sung,Yoo Doo-Hyun,Lee Su-Jae,An Sungkwan,Rhee Chang-Hun,Hong Seok-Il,Choe Tae-Boo,Park In-Chul

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Validating survivin as a cancer therapeutic target

2. Targeting cyclooxygenase-2 in human neoplasia

3. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

4. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics approach in cancer treatment with focus on lung and breast cancer;Cancer Epigenetics and Nanomedicine;2024

2. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets;International Journal of Molecular Sciences;2021-10-28

3. Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis;BMC Cancer;2017-01-21

4. Epigenetics in non-small cell lung cancer: from basics to therapeutics;Translational Lung Cancer Research;2016-04

5. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation;Oncotarget;2014-12-31